Navigation Links
Kiwa Bio-Tech Confirms Joint Venture Agreement With Shijiazhuang Huaxing Animal Medicine Co., Ltd.
Date:5/13/2008

BEIJING and CLAREMONT, Calif., May 13 /Xinhua-PRNewswire-FirstCall/ -- Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) announced finalization of an agreement establishing a joint venture company capable of producing Kiwa's AF-01 anti-viral product.

On May 9, General Manager of Shijiazhuang Huaxing Animal Medicine Co., Ltd. (''Huaxing''), Mr. Ruijun Li and his associates visited Kiwa's headquarters in Beijing for the final round of negotiations toward setting up a proposed joint-venture. Both parties had extensively negotiated on the terms of the joint-venture contract and finally confirmed all terms of the contract.

The signing ceremony will be held next week, after the company name is approved by the local Administration of Industry and Commerce.

ABOUT AF-01 ANTI-VIRAL FEED ENHANCEMENT AND AEROSOL

In May 2006, Kiwa acquired AF-01 Anti-viral Aerosol technology for veterinary medicine applications including the exclusive production right and other related rights to produce an anti-viral aerosol drug for use with animals from Jinan Kelongboao Bio-Tech Co., Ltd. ("JKB"), which is affiliated with Chinese Academy of Medical Sciences. The AF-01 aerosol technology is a broad-spectrum anti-viral agent with potent inhibitory and/or viricidal effects on a variety of RNA viruses found in animals and fowls such as bird flu. Kiwa's hope is to develop a commercialized product in the form of a spray for applying in fowl houses and other animal holding facilities to prevent and cure virus-caused diseases.

ABOUT SHIJIAZHUANG HUAXING ANIMAL MEDICINE CO., LTD.

Huaxing was founded in 1996. Huaxing is supported by animal husbandry and veterinary medicine agencies at both provincial and municipal levels. Huaxing has focused on building strong co-operative relationships with academic institutions such as the Agricultural University of Heibei and Hebei University of Science & Technology. Huaxing has developed: 12-series o
'/>"/>

SOURCE Kiwa Bio-Tech Products Group Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Kiwa Bio-Tech 1st Quarter Revenues Increase 57.8% - $2.18 Million
2. Kiwa Bio-Tech Year-End Revenues Increase 264% - Exceed $9.1 Million
3. Kiwa Bio-Tech New Bio-Fertilizer Product Granted Initial Fertilizer Registration Certificate By Ministry of Agriculture of the PRC
4. Kiwa Bio-Tech Products Group Discusses Cooperative Research With the University of Waterloo, Canada
5. Kiwa Bio-Tech Products Group Discusses Cooperative Efforts With Canadian Agricultural Ministry and Canadian Company
6. Kiwa Bio-Tech Ships 114 Tons of Bio-Fertilizer in Fourth Quarter of 2007
7. Kiwa Bio-Tech Animal Feed Volume Increased 25% in Fourth Quarter of 2007
8. Kiwa Bio-Tech Products Group Holds Meetings to Build Distribution Network
9. Kiwa Bio-Tech Products Group Holds a Fertilizer Products Exhibition in Hebei
10. Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million
11. Align Technology, Inc. Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific & Medical Equipment, and Bio-Technology Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... Massachusetts, USA (PRWEB) November 26, 2014 ... more accuracy, additive systems to enable 3D manufacture at ... analyzing road conditions are among finalists in nine categories ... . The awards are sponsored by SPIE, the ... Photonics Media . , Winners will be announced by ...
(Date:11/26/2014)... Dallas, Texas (PRWEB) November 26, 2014 ... Bifluoride Industryā€¯ is a professional and in-depth research ... Ammonium Bifluoride information, like its definition, classification, application, ... overview. This report covers the international market analysis, ... (such as the US, Europe, Asia, China, Japan ...
(Date:11/26/2014)... , Nov. 26, 2014 The announced ... indicate the company is looking to expand in non-healthcare ... sales.  The healthcare market research firm says that  Siemens ... Kalorama Information,s biennial survey of the IVD market , ... any change in its composition would likely affect IVD ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 On January, ... the Baltimore and Washington D.C. science community to the ... The event, sponsored by the Protein Society, will take ... University Center, Room 312. Through discussion, presentations and ... structural importance of proteins, their role in the industry ...
Breaking Biology Technology:Finalists Named for 2015 Prism Awards for Photonics Innovation 2Finalists Named for 2015 Prism Awards for Photonics Innovation 3Finalists Named for 2015 Prism Awards for Photonics Innovation 4Finalists Named for 2015 Prism Awards for Photonics Innovation 5Ammonium Bifluoride Market International Analysis of Manufacturing, Technology & Trends Now at ReportsnReports.com 2Ammonium Bifluoride Market International Analysis of Manufacturing, Technology & Trends Now at ReportsnReports.com 3Kalorama: Sale of Three Siemens Healthcare Units Raises Questions About Firm's IVD Future 2
... ... President, Marketing and Sales, and James Carr Promoted To ... Capacity in China -, - Details to be Presented at Investor Briefing Today at 12 p.m. Eastern ... Time -, SOUTH SAN FRANCISCO, Calif., ...
... Ill. A hybrid device combining force and fluorescence ... made possible the accurate detection of nanometer-scale motion of ... resonance energy transfer and an optical trap, we now ... of a biomolecule at an extremely low applied force, ...
... Oct. 11 Timely Data Resources, Inc.,has recently released ... and Therapy,Review (DTR) reports. Reports are available through subscription ... be purchased,individually at marketresearch.com. These reports offer a quick ... Each overview is,generally 10 to 15 pages in length, ...
Cached Biology Technology:Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 2Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 3Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 4Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 5Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 6Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM) 7New force-fluorescence device measures motion previously undetectable 2New force-fluorescence device measures motion previously undetectable 3
(Date:11/3/2014)... and preterm birth are linked to increased risk for ... the American College of Rheumatology (ACR) journal, Arthritis ... and pre-term babies were not at greater risk of ... According to the ACR, 27 million Americans over the ... of OA range from mild to severe and include ...
(Date:11/2/2014)... NEW ORLEANS, LA (2 November 2014)—In support of a ... the Bill & Melinda Gates Foundation today announced an ... PATH Malaria Vaccine Initiative (MVI) in building new vaccines ... and help realize the "accelerating to zero" agenda. Such ... providing what could be called an "immunological bed net." ...
(Date:11/2/2014)... and bump into a biologist . . . , While ... sketch, researchers have taken this premise and applied it to ... in the rising oceans of genomic data. , In this ... studies are publishing at a dizzying rate. The challenge is ... the noise (and there is no shortage of noise). , ...
Breaking Biology News(10 mins):Preterm, low birth-weight babies may need new hips in adulthood 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 3New malaria vaccines to prevent infection and block transmission get a shot in the arm 4Mutant models 2Mutant models 3Mutant models 4
... the molecular details that show how a viral protein ... them to continuously grow, thereby predisposing people to certain ... of the most common human viruses in the world ... Burkitt's lymphoma as well as the epithelial cell cancer, ...
... aimed at directly controlling the expression of genes by turning ... to drugs for the treatment or cure of many diseases, ... disease starts at the level of malfunctioning gene expression, or ... of pharmacology and biochemistry. "This is an approach that could ...
... cells make their vital connections, embryonic cells move to ... in to destroy pathogenic organisms, and cancer cells metastasize, ... migrations didn't know how cells determined where to go. ... a fragment of a protein that senses chemicals that ...
Cached Biology News:U of T researchers map role of Epstein-Barr virus in cancer 2Gene silencing technique offers new strategy for treating, curing disease 2New understanding of cell movement may yield ways to brake cancer's spread 2